BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11013644)

  • 21. Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.
    Lai DM; Lin SM; Tu YK; Kao MC; Hung CC
    J Formos Med Assoc; 1993 Mar; 92(3):220-6. PubMed ID: 8102273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation.
    Yoshida J; Kajita Y; Wakabayashi T; Sugita K
    Acta Neurochir (Wien); 1994; 127(1-2):55-9. PubMed ID: 7942182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retreatment of intracranial gliomas.
    Landy HJ; Feun L; Schwade JG; Snodgrass S; Lu Y; Gutman F
    South Med J; 1994 Feb; 87(2):211-4. PubMed ID: 8115886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery.
    De Witt Hamer PC; Ho VKY; Zwinderman AH; Ackermans L; Ardon H; Boomstra S; Bouwknegt W; van den Brink WA; Dirven CM; van der Gaag NA; van der Veer O; Idema AJS; Kloet A; Koopmans J; Ter Laan M; Verstegen MJT; Wagemakers M; Robe PAJT;
    J Neurooncol; 2019 Sep; 144(2):313-323. PubMed ID: 31236819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reoperation for glioma.
    Berger MS; Tucker A; Spence A; Winn HR
    Clin Neurosurg; 1992; 39():172-86. PubMed ID: 1333931
    [No Abstract]   [Full Text] [Related]  

  • 26. Survival and prognostic factors of anaplastic gliomas.
    Nuño M; Birch K; Mukherjee D; Sarmiento JM; Black KL; Patil CG
    Neurosurgery; 2013 Sep; 73(3):458-65; quiz 465. PubMed ID: 23719055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of malignant astrocytomas with repetitive resections: a longitudinal study.
    Azizi A; Black P; Miyamoto C; Croul SE
    Isr Med Assoc J; 2001 Apr; 3(4):254-7. PubMed ID: 11344836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study.
    Fulton DS; Urtasun RC; Scott-Brown I; Johnson ES; Mielke B; Curry B; Huyser-Wierenga D; Hanson J; Feldstein M
    J Neurooncol; 1992 Sep; 14(1):63-72. PubMed ID: 1335044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of conventional radiotherapy in malignant gliomas:].
    Shibamoto Y; Yamashita J; Takahashi M; Yamasaki T; Kikuchi H; Abe M
    Gan No Rinsho; 1989 Sep; 35(11):1240-6. PubMed ID: 2554004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas.
    Vitanovics D; Sipos L; Afra D
    Neoplasma; 2002; 49(5):342-5. PubMed ID: 12458335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial.
    Brady LW; Miyamoto C; Woo DV; Rackover M; Emrich J; Bender H; Dadparvar S; Steplewski Z; Koprowski H; Black P
    Int J Radiat Oncol Biol Phys; 1992; 22(1):225-30. PubMed ID: 1309204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Surgery and Further Treatment of Progressive Glioblastoma.
    Woernle CM; Péus D; Hofer S; Rushing EJ; Held U; Bozinov O; Krayenbühl N; Weller M; Regli L
    World Neurosurg; 2015 Aug; 84(2):301-7. PubMed ID: 25797075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant astrocytic gliomas in children.
    Marchese MJ; Chang CH
    Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative radiation therapy for malignant glioma.
    Sakai N; Yamada H; Andoh T; Hirata T; Nishimura Y; Miwa Y; Shimizu K; Yanagawa S
    Neurol Med Chir (Tokyo); 1991 Nov; 31(11):702-7. PubMed ID: 1723157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.
    Winger MJ; Macdonald DR; Cairncross JG
    J Neurosurg; 1989 Oct; 71(4):487-93. PubMed ID: 2552044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres.
    Polin RS; Marko NF; Ammerman MD; Shaffrey ME; Huang W; Anderson FA; Caputy AJ; Laws ER
    J Neurosurg; 2005 Feb; 102(2):276-83. PubMed ID: 15739555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What progress has been made in surgical management of patients with astrocytoma and oligodendroglioma in Australia over the last two decades?
    Smith SF; Simpson JM; Sekhon LH
    J Clin Neurosci; 2005 Nov; 12(8):915-20; discussion 921. PubMed ID: 16326271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
    Sullivan FJ; Herscher LL; Cook JA; Smith J; Steinberg SM; Epstein AH; Oldfield EH; Goffman TE; Kinsella TJ; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):583-90. PubMed ID: 7928489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-operations of supratentorial anaplastic astrocytomas.
    Sipos L; Afra D
    Acta Neurochir (Wien); 1997; 139(2):99-104. PubMed ID: 9088366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.